Division of Radiology, Geneva University Hospital, Rue Gabrielle-Perret-Gentil 4, 1211, Geneva 4, Switzerland,
Eur Radiol. 2015 Jun;25(6):1665-71. doi: 10.1007/s00330-014-3563-5. Epub 2014 Dec 21.
To determine whether CT pulmonary angiography (CTPA) using low mA setting reconstructed with model-based iterative reconstruction (MBIR) is equivalent to routine CTPA reconstructed with filtered back projection (FBP).
This prospective study was approved by the institutional review board and patients provided written informed consent. Eighty-two patients were examined with a low mA MBIR-CTPA (100 kV, 20 mA) and 82 patients with a standard FBP-CTPA (100 kV, 250 mA). Region of interests were drawn in nine pulmonary vessels; signal-to-noise ratio (SNR) and contrast-to-noise ratio (CNR) were calculated. A five-point scale was used to subjectively evaluate the image quality of FBP-CTPA and low mA MBIR-CTPA.
Compared to routine FBP-CTPA, low mA MBIR-CTPA showed no differences in the attenuation measured in nine pulmonary vessels, higher SNR (56 ± 19 vs 43 ± 20, p < 0.0001) and higher CNR (50 ± 17 vs 38 ± 18, p < 0.0001) despite a dose reduction of 93 % (p < 0.0001). The subjective image quality of low mA MBIR-CTPA was quoted as diagnostic in 98 % of the cases for patient with body mass index less than 30 kg/m(2).
Low mA MBIR-CTPA is equivalent to routine FBP-CTPA and allows a significant dose reduction while improving SNR and CNR in the pulmonary vessels, as compared with routine FBP-CTPA.
• Low mA MBIR-CTPA is equivalent to routine FBP-CTPA. • MBIR-CTPA may be achieved with drastic (93 %) dose reduction. • Low mA MBIR-CTPA should be studied in the setting of suspected PE.
确定使用基于模型的迭代重建(MBIR)的低毫安设置进行 CT 肺动脉造影(CTPA)是否与使用滤波反投影(FBP)进行的常规 CTPA 相当。
这项前瞻性研究得到了机构审查委员会的批准,患者提供了书面知情同意书。82 例患者接受低毫安 MBIR-CTPA(100 kV,20 mA)检查,82 例患者接受标准 FBP-CTPA(100 kV,250 mA)检查。在九个肺动脉中画出感兴趣区域;计算信噪比(SNR)和对比噪声比(CNR)。使用五分制对 FBP-CTPA 和低毫安 MBIR-CTPA 的图像质量进行主观评价。
与常规 FBP-CTPA 相比,低毫安 MBIR-CTPA 在九个肺动脉中的衰减测量值无差异,但 SNR 更高(56±19 比 43±20,p<0.0001)和 CNR 更高(50±17 比 38±18,p<0.0001),尽管剂量降低了 93%(p<0.0001)。对于 BMI 小于 30 kg/m2 的患者,低毫安 MBIR-CTPA 的主观图像质量有 98%被评为诊断性。
与常规 FBP-CTPA 相比,低毫安 MBIR-CTPA 等效,可在不影响肺血管 SNR 和 CNR 的情况下显著降低剂量。
低毫安 MBIR-CTPA 与常规 FBP-CTPA 等效。
MBIR-CTPA 可在大幅(93%)降低剂量的情况下实现。
低毫安 MBIR-CTPA 应在疑似 PE 的情况下进行研究。